ISRCTN47219228已完成未知
The use of metformin in patients with polycystic ovarian syndrome requiring treatment with in vitro fertilisation (IVF)
Department of Health (UK)0 个研究点目标入组 100 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Patients with PCOS
排除标准
- •Does not meet inclusion criteria
研究者
相似试验
尚未招募
4 期
A randomized trial of Metformin in autosomal dominant polycystic kidney disease for reducing rate of decline of kidney functioCTRI/2024/08/072241Indian Council of Medical Research
已完成
2 期
Evaluation of effectiveness of Metformin and pioglitazone in women with polycystic ovary syndromePolycystic ovary syndrome.Polycystic ovarian syndromeIRCT201403101836N7Shahid Sadoughi University of Medical Sciences75
Unknown
不适用
Efficacy of Metformin in Lean Women With Polycystic Ovary SyndromePolycystic Ovary SyndromeNCT00319293Aarhus University Hospital Skejby20
已完成
不适用
Effects of metformin and pioglitazone in polycystic ovarian syndromePolycystic ovarian syndrome.Endocrine nutritional and metabolic diseasesIRCT201008094179N3Vice-chancellor for research, Kermanshah University of Medical Science56
进行中（未招募）
1 期
PregMet 2 studyPoly Cystic Ovarial Syndrome (PCOS) in pregnant women. PCOS should be diagnosed according to the Rotterdam Consensus criterias:- at least 2 out of 3 criterias1.PCO in at least one ovary2.Oligo-/anovulation (clinically diagnosed as oligo-/amenorrhea,i.e. menstrual cycles > 35 days or <10 menstruations/year3.Hyperandrogenismclinical or biochemicalMedDRA version: 14.1Level: LLTClassification code 10065161Term: Polycystic ovarian syndromeSystem Organ Class: 100000004872EUCTR2011-002203-15-SETNU, Norwegian University of Science and Technology1,000